A 2017 study by Zhao et al. reported that CRC tumors overexpress the chemokine C-X-C motif chemokine ligand 5 (CXCL5), which is also a poor prognosis factor and an EMT driver [110]. The gene discussed is CXCL5; the disease is colorectal carcinoma.